MetaCap

Genelux Insider Trades

NASDAQ: GNLXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.17-0.11 (-4.82%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
24 · $340.56K
Shares bought / sold
0 / 115.77K
Net activity
Net selling $340,565

Genelux insider activity

Over the last 12 months, Genelux insiders reported 33 transactions on SEC Form 4: 0 open-market purchases and 24 sales. Insiders bought $0 and sold $340,565 worth of stock, for net insider selling of $340,565. The largest seller was Zindrick Thomas, with $124,016 in reported sales.

The most recent filing shows Zindrick Thomas (President and CEO) selling 3,089 shares at $2.05 on Nov 3, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GNLX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

GNLX insider transactions

Genelux insider transactions
DateInsiderTypeSharesValueFiling
Nov 3, 2026Cappello JosephChief Technical OfficerSale668$1.36KForm 4
Nov 3, 2026Yu YongChief Scientific OfficerSale668$1.34KForm 4
Nov 3, 2026Zindrick ThomasPresident and CEOSale3,089$6.32KForm 4
Aug 31, 2026Yu YongChief Scientific OfficerSale9,683$26.66KForm 4
Aug 31, 2026Zindrick ThomasPresident and CEOSale34,463$91.90KForm 4
Aug 31, 2026Cappello JosephChief Technical OfficerSale10,257$28.11KForm 4
Aug 4, 2026Cappello JosephChief Technical OfficerSale653$1.92KForm 4
Aug 4, 2026Zindrick ThomasPresident and CEOSale3,023$8.91KForm 4
Aug 4, 2026Yu YongChief Scientific OfficerSale653$1.92KForm 4
Jul 1, 2026Smither John WDirectorSale12,000$34.90KForm 4
Jun 16, 2026Smither John WDirectorAward28,409—Form 4
Jun 16, 2026Tyree James LDirectorAward28,409—Form 4
Jun 16, 2026Cappello JosephChief Technical OfficerAward174,841—Form 4
Jun 16, 2026Yu YongChief Scientific OfficerAward119,318—Form 4
Jun 16, 2026Mirabelli MaryDirectorAward28,409—Form 4
Jun 16, 2026Thomas JohnDirectorAward28,409—Form 4
Jun 16, 2026Zindrick ThomasPresident and CEOAward730,601—Form 4
Jun 16, 2026Groen EricGeneral CounselAward233,957—Form 4
Jun 16, 2026Pulisic MatthewChief Financial OfficerAward278,906—Form 4
Jun 3, 2026Smalling RalphHead of RegulatorySale192$562.56Form 4
Jun 1, 2026Thomas JohnDirectorSale10,000$29.80KForm 4
May 11, 2026Cappello JosephChief Technical OfficerSale605$1.80KForm 4
May 11, 2026Smalling RalphHead of RegulatorySale270$804.49Form 4
May 11, 2026Zindrick ThomasPresident and CEOSale2,798$8.23KForm 4
May 11, 2026Yu YongChief Scientific OfficerSale605$1.80KForm 4
Mar 25, 2026Smalling RalphHead of RegulatorySale240$602.40Form 4
Mar 24, 2026Zindrick ThomasPresident and CEOSale3,582$8.67KForm 4
Mar 24, 2026Yu YongSVP, Clinical DevelopmentSale906$2.19KForm 4
Mar 24, 2026Cappello JosephChief Technical OfficerSale906$2.19KForm 4
Mar 24, 2026Smalling RalphHead of RegulatorySale345$834.90Form 4
Mar 2, 2026Thomas JohnDirectorSale10,000$28.96KForm 4
Dec 5, 2025Smalling RalphHead of RegulatorySale165$773.85Form 4
Dec 1, 2025Thomas JohnDirectorSale10,000$50.01KForm 4
Nov 17, 2025Smalling RalphHead of RegulatorySale343$1.84KForm 4
Nov 17, 2025Cappello JosephChief Technical OfficerSale973$5.22KForm 4
Nov 17, 2025Zindrick ThomasPresident and CEOSale4,509$24.21KForm 4
Nov 17, 2025Yu YongSVP, Clinical DevelopmentSale973$5.22KForm 4
Sep 3, 2025Smalling RalphHead of RegulatorySale580$1.95KForm 4
Sep 1, 2025Smalling RalphHead of RegulatoryAward10,000—Form 4
Aug 27, 2025Smalling RalphHead of RegulatoryAward26,230—Form 4
Aug 27, 2025Zindrick ThomasPresident and CEOAward361,200—Form 4
Aug 27, 2025Thomas JohnDirectorAward22,283—Form 4
Aug 21, 2025Smalling RalphHead of RegulatorySale1,244$4.18KForm 4
Aug 21, 2025Cappello JosephChief Technical OfficerSale1,463$4.91KForm 4
Aug 21, 2025Cappello JosephChief Technical OfficerSale1,270$4.22KForm 4
Aug 21, 2025Zindrick ThomasPresident and CEOSale12,673$42.16KForm 4
Aug 21, 2025Yu YongSVP, Clinical DevelopmentSale3,219$10.81KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related